|  |  |  |  |  | Systolic blood pressure categories (mmHg) |  |  | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Primary author, year | Country | Baseline study, year | Follow-up, years | N (% Female) | Age, year | < 120n (% Female) | 120–129 n (% Female) | 130–139n (% Female) | ≥140n (% Female) | Total events (% Female) | |
Jee et al (2005)a, [17] | Korea | 1990–1992 | 10b | 157,377 (33.6) | 35–59d | 55,940 (53.3) | 67,307 (26.2) |  | 34,135 (15.8) | 5478 (27.9) | CKD |
Kanno et al (2012)a, [18] | Japan | 1993–2007 | 6.5b | 2150 (63.4) | 60.3b | 586 (75.8) | 815 (61.2) |  | 749 (56.2) | 461 (62.7) | |
Tohidi et al (2012)a, [19] | Iran | 1999–2001 | 9.9b | 3313 (56.1) | ≥ 20b | NA | NA | NA | NA | 723 (71.5) | |
Komura et al. (2013) [20] | Japan | 1999 | 10b | 1506 (68.6) | 58.2b | NA | NA | NA | NA | 466 (28.9) | |
Cao et al (2014)a, [21] | China | 2006–2011 | 4.5c | 1703 (46) | 45.6b | 828 (64.2) | 546 (31.7) |  | 329 (24.0) | 194 (31) | |
Yano et al. (2014) [22] | Japan | 2008 | 3b | 42,625 (63.8) | 60c | 17,759 (68.6) | 14,064 (60.9) | 10,802 (59.5) | NA | 2142 (57.4) | |
Xue et al. (2015) [23] | China | 2006–2007 | 3.9c | 32,385 (27.2) | 46.4b | 12,351 (36.3) | 20,034 (21.6) |  | NA | 601 (54.9) | |
Wan et al. (2019) [24] | China | 2011–2012 | 6c | 156,469 (58.5) | 64.3b | NA | NA |  | NA | 30,993 (NA) | |
Haroun et al (2003)a, [25] | US | 1974 | 20b | 23,534 (59.2) | NA | 3686 (78.8) | 5333 (65.7) | 4513 (54.8) | 10,002 (50.5) | 143 (NA) | ESRD |
Tozawa et al. (2003) [26] | Japan | 1983–1984 | 17b | 98,759 (52.5) | 50b | 23,187 (64.8) | 22,835 (48.9) | 16,840 (45.9) | 35,897 (50.1) | 400 (42.3) | |
Pscheidt et al. (2015) [27] | Austria | 1988–2005 | 17.5b | 185,341 (53.9) | 38.9c | 117,658 (NA) | NA | NA | 67,506 (NA) | 403 (39.2) | |
Leiba et al (2017)a, [28] | Israel | 1977–2013 | 16.8c | 2,194,635 (41.7) | 16–19d | 1,465,733 (43.4) | 442,077 (36.5) |  | 286,825 (41) | 690 (23.3) |